1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDeepTech Catalyst Bio is sponsored by Biotechnology and Biological Sciences Research Council (BBSRC) and Science and Technology Facilities Council (STFC). This programme supports early-stage biotechnology businesses to develop products and reach market.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
BBSRC-STFC DeepTech Catalyst Bio 2026 – UKRI Funding opportunity: BBSRC-STFC DeepTech Catalyst Bio 2026 Biotechnology and Biological Sciences Research Council (BBSRC) , Science and Technology Facilities Council (STFC) 11 May 2026 9:00am UK time 14 September 2026 11:59pm UK time The BBSRC-STFC DeepTech Catalyst Bio (DTC Bio) is a business incubator programme designed to support early-stage biotechnology start-ups in achieving their commercial potential.
£10,000 innovation voucher for R&D activity technical, commercial, business and intellectual property support networking opportunities and introductions to investors, customers, and key sector stakeholders access to a number of UKRI campuses DTC Bio is open to UK-registered companies under five years old that are majority-owned by founders and employees and that have one or more of the following: received a Biotechnology and Biological Sciences Research Council (BBSRC) or other UK Research and Innovation (UKRI) grant to support the research underpinning the product or service received an Innovate UK or other UKRI commercialisation grant to take forward a bioscience innovation to address a market opportunity received support from UKRI-supported accelerator or pre-incubation programme The technology underpinning the products or services being carried forward by the company must be within BBSRC remit.
The company must be able to demonstrate that they are beyond the concept stage of product development or market penetration, or both. The technology underpinning the products or services developed by the company must be building on a previous support from BBSRC, UKRI or UKRI-supported accelerator or pre-incubation programme. The research must be taking forward a bioscience innovation to address a clear market opportunity.
The technology must be either: interact with a biological entity involve a biological process address a biological challenge We will not accept applications based on medical or clinical devices and therapeutics being developed solely for a specific end-point clinical utility, including diagnostics. We strongly advise you to contact us if you are unsure whether your application fits the scope of the DTC Bio programme.
The DTC Bio will provide access to a number of UKRI campuses: Science and Technology Facilities Council (STFC) Sci-Tech Daresbury campus BBSRC campuses of Rothamsted Enterprises and AberInnovation additional specialist support available from The Pirbright Institute Please note that the DTC Bio programme was formerly called the BBSRC-STFC Biotechnology Business Incubation Centre (Bio BIC).
Complete the DTC Bio expression of interest application form . Companies are strongly encouraged to submit their expressions of interest (EOIs) as early as possible, and no later than 11:59pm on 16 August 2026. Each company may submit only one EOI.
Following approval of the EOI, successful applicants will be invited to submit a full application by 14 September 2026 and will be provided with the application template. How we will assess your application All applications will go through a competitive selection process. Submissions will be reviewed on an ongoing basis.
EOIs will be reviewed in phases according to the following deadlines: tranche one: 11:59pm on 26 June 2026 tranche two: 11:59pm on 17 July 2026 tranche three (final): 11:59pm on 16 August 2026 Following approval of the EOI, successful applicants will be invited to submit a full application by 14 September 2026 and will be provided with the application template.
Applicants may request feedback on draft applications prior to the final application deadline, 14 September 2026. Early submission is strongly encouraged to allow sufficient time to incorporate feedback and strengthen the final application. Successful applicants will be invited to present at the in-person evaluation board taking place on 20 to 22 October.
Ask about this funding opportunity Email: bio_enquiries@stfc. ac. uk Webinar for potential applicants We will hold a webinar on Thursday 18 June 2026 at 14.
00. This will provide more information about the programme and offer a chance to ask questions. Register for the webinar .
This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .
According to the current listing, eligibility includes: UK-registered businesses less than five years old, majority-owned by founders and employees, and that have previously received support from BBSRC, UKRI, Innovate UK, or a UKRI-supported accelerator. Confirm the full requirements in the official notice before applying.
The current listing shows £50,000 (R&D funding) + £10,000 (innovation voucher). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
DeepTech Catalyst Bio is funded by Biotechnology and Biological Sciences Research Council (BBSRC) and Science and Technology Facilities Council (STFC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleOn July 22, 2026 the White House committed more than $5 billion to expand the Genesis Mission — the government-wide 'AI for science' effort — announcing 278 first projects and 14 National Science and Technology Challenges spanning health, energy, infrastructure, manufacturing, and national security. More than 15 federal agencies are contributing awards, datasets, and facilities. Here is how the pieces fit, why it reorganizes the science-funding map, and how to position for the awards flowing out of it.
Read articleOn July 22, 2026 the White House announced more than $5 billion and 15-plus federal agencies behind the Genesis Mission — a national effort to point AI at the hardest problems in science. Here is what the mission actually funds, how its five National Science and Technology Challenges map to real solicitations already opening, and how a research team or small business should position for the money flowing out of it.
Read article